CIA
GILD icon

Cascade Investment Advisors’s Gilead Sciences GILD Stock Holding History

Cascade Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Hold
2,760
– – 0.19% 99
2026
Q1 		$385K Hold
2,760
– – 0.23% 100
2025
Q4 		$339K Hold
2,760
– – 0.2% 102
2025
Q3 		$306K Hold
2,760
– – 0.19% 102
2025
Q2 		$306K Hold
2,760
– – 0.2% 102
2025
Q1 		$309K Hold
2,760
– – 0.21% 99
2024
Q4 		$255K Hold
2,760
– – 0.16% 104
2024
Q3 		$231K Buy
+2,760
New +$211K 0.15% 106
2024
Q2 		– Sell
-2,760
Closed -$202K – 113
2024
Q1 		$202K Sell
2,760
-125
-4% -$9.61K 0.13% 114
2023
Q4 		$234K Hold
2,885
– – 0.17% 102
2023
Q3 		$216K Hold
2,885
– – 0.17% 103
2023
Q2 		$222K Hold
2,885
– – 0.17% 108
2023
Q1 		$239K Sell
2,885
-4,670
-62% -$387K 0.19% 99
2022
Q4 		$649K Sell
7,555
-15,902
-68% -$1.26M 0.54% 84
2022
Q3 		$1.84M Sell
23,457
-1,260
-5% -$79.5K 1.58% 7
2022
Q2 		$1.53M Sell
24,717
-1,508
-6% -$93.4K 1.2% 17
2022
Q1 		$1.56M Buy
26,225
+1,443
+6% +$92.2K 0.95% 35
2021
Q4 		$1.8M Buy
24,782
+187
+0.8% +$12.9K 1.05% 25
2021
Q3 		$1.72M Sell
24,595
-705
-3% -$49.5K 1.12% 22
2021
Q2 		$1.74M Buy
25,300
+145
+0.6% +$9.68K 1.1% 27
2021
Q1 		$1.63M Buy
25,155
+395
+2% +$25.5K 1.06% 31
2020
Q4 		$1.44M Buy
24,760
+910
+4% +$54.9K 1.06% 28
2020
Q3 		$1.51M Buy
23,850
+975
+4% +$67.6K 1.28% 18
2020
Q2 		$1.76M Sell
22,875
-755
-3% -$57.9K 1.66% 7
2020
Q1 		$1.77M Sell
23,630
-530
-2% -$36.6K 1.95% 5
2019
Q4 		$1.57M Sell
24,160
-180
-0.7% -$11.7K 1.2% 17
2019
Q3 		$1.54M Buy
24,340
+2,470
+11% +$161K 1.19% 18
2019
Q2 		$1.48M Buy
21,870
+720
+3% +$47.4K 1.25% 19
2019
Q1 		$1.37M Sell
21,150
-100
-0.5% -$6.65K 1.23% 17
2018
Q4 		$1.33M Sell
21,250
-250
-1% -$17.5K 1.34% 19
2018
Q3 		$1.66M Buy
21,500
+315
+1% +$23.8K 1.4% 14
2018
Q2 		$1.5M Sell
21,185
-1,770
-8% -$125K 1.34% 17
2018
Q1 		$1.73M Buy
22,955
+2,900
+14% +$231K 1.36% 17
2017
Q4 		$1.44M Sell
20,055
-100
-0.5% -$7.59K 1.14% 33
2017
Q3 		$1.63M Buy
20,155
+90
+0.4% +$6.88K 1.36% 20
2017
Q2 		$1.42M Buy
20,065
+3,625
+22% +$241K 1.21% 31
2017
Q1 		$1.12M Buy
16,440
+2,175
+15% +$153K 0.98% 50
2016
Q4 		$1.02M Buy
+14,265
New +$1.06M 0.87% 59
2016
Q2 		$1.13M Buy
+13,565
New +$1.2M 1.09% 47

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Cascade Investment Advisors's GILD Position: Q2 2026 in Review

Cascade Investment Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,760 shares worth $349K. The position accounts for 0.19% of the portfolio, ranked #99.

Cascade Investment Advisors first reported a position in GILD in Q2 2016 and has held it in 39 quarters since. The position peaked at $1.84M in Q3 2022. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cascade Investment Advisors held 2,760 shares of Gilead Sciences worth $349K as of Q2 2026.
  • Cascade Investment Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.19% of Cascade Investment Advisors's portfolio in Q2 2026, its #99 holding.
  • Cascade Investment Advisors first reported a position in Gilead Sciences in Q2 2016 and has held it in 39 quarters since.
  • Cascade Investment Advisors's Gilead Sciences position peaked at $1.84M in Q3 2022.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cascade Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.